TGFBR1 and neoplasm: The immunoinhibitors affect some cancer types among different clusters, including BLCA, BRCA, CESC, ESCA, GBM, HNSC, KIRP, KIRC, LUAD, LUSC, LIHC, OV, PRAD, PCPG, READ, STAD, THCA, and UCEC; IL10RB, KDR and TGFBR1 are significantly affected most tumor types (Figure 7A).